Sushmita Chanda

1.9k total citations
48 papers, 1.1k citations indexed

About

Sushmita Chanda is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Sushmita Chanda has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 18 papers in Hepatology and 10 papers in Molecular Biology. Recurrent topics in Sushmita Chanda's work include Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (13 papers) and Respiratory viral infections research (9 papers). Sushmita Chanda is often cited by papers focused on Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (13 papers) and Respiratory viral infections research (9 papers). Sushmita Chanda collaborates with scholars based in United States, Belgium and France. Sushmita Chanda's co-authors include Stephanie Padilla, Spencer R. Mortensen, Virginia C. Moser, Julian Symons, Lawrence M. Blatt, Qingling Zhang, Leo Beigelman, Michael Hooper, Matthew W. McClure and Patrick F. Smith and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Hepatology.

In The Last Decade

Sushmita Chanda

41 papers receiving 1.1k citations

Peers

Sushmita Chanda

EPIDE

HTM

PHARM

Karen Regan United States

John G. Lamb United States

Amrita Roy India

A. W. Singer United States

J. A. McCay United States

Jiajun Han China

Reza J. Rasoulpour United States

Khalid Majid Fazili India

K. Karpinski Canada

Yazeed A. Al‐Sheikh Saudi Arabia

Karen Regan United States

Sushmita Chanda

77 ×0.2

54 ×0.1

EPIDE

186 ×0.6

HTM

133 ×0.7

111 ×0.7

PHARM

Citations per year, relative to Sushmita Chanda Sushmita Chanda (= 1×) peers Karen Regan

Countries citing papers authored by Sushmita Chanda

Since Specialization

Citations

This map shows the geographic impact of Sushmita Chanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sushmita Chanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sushmita Chanda more than expected).

Fields of papers citing papers by Sushmita Chanda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sushmita Chanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sushmita Chanda. The network helps show where Sushmita Chanda may publish in the future.

Co-authorship network of co-authors of Sushmita Chanda

This figure shows the co-authorship network connecting the top 25 collaborators of Sushmita Chanda. A scholar is included among the top collaborators of Sushmita Chanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sushmita Chanda. Sushmita Chanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gane, Edward, Christian Schwabe, Min Wu, et al.. (2025). A Phase 1 study of the safety, tolerability, and pharmacokinetics of ALG-000184 (pevifoscorvir sodium), a novel Class E capsid assembly modulator, in healthy participants. Antiviral Therapy. 30(6). 232118715–232118715.

Agarwal, Kosh, Edward Gane, Man‐Fung Yuen, et al.. (2024). WED-361 Dosing with the Capsid Assembly Modulator ALG-000184 in Untreated HBeAg Negative CHB Subjects Results in Potent Antiviral Effects Including Suppression of HBV DNA/RNA and Declines in HBcrAg Levels. Journal of Hepatology. 80. S806–S806.

Jekle, Andreas, Suping Ren, April Kinkade, et al.. (2023). Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models. International Journal of Molecular Sciences. 24(22). 16274–16274. 5 indexed citations

Hou, Jinlin, Yanhua Ding, Junqi Niu, et al.. (2023). ALG-000184, a capsid assembly modulator, dosed with entecavir for up to 28 weeks is well tolerated and resulted in substantial declines in surface antigen levels in untreated Hepatitis B e antigen positive subjects with chronic hepatitis B. Journal of Hepatology. 78. S112–S113.

Gupta, Kusum, Megan Fitzgerald, Jin Tae Hong, et al.. (2023). Pharmacodynamic durability of ALG-125755, a GalNAc-conjugated siRNA, correlated with total and RNA induced complex (RISC) bound siRNA in mouse liver. Journal of Hepatology. 78. S1029–S1029. 1 indexed citations

McClure, Matthew W., Julian Symons, Sushmita Chanda, et al.. (2023). Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results. PLoS ONE. 18(7). e0288271–e0288271. 14 indexed citations

Zhang, Qingling, Sandrine Vendeville, V. N. Serebryany, et al.. (2020). ALG-000184, a prodrug of capsid assembly modulator ALG-001075, demonstrates best-in-class preclinical characteristics for the treatment of chronic hepatitis B. Journal of Hepatology. 73. S880–S881. 4 indexed citations

Luong, Xuan G., Sarah Stevens, Andreas Jekle, et al.. (2020). Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH). PLoS ONE. 15(12). e0240338–e0240338. 31 indexed citations

McClure, Matthew W., Elina Berliba, Tengiz Tsertsvadze, et al.. (2018). Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects. PLoS ONE. 13(10). e0204974–e0204974. 8 indexed citations

10.

Gane, Edward, Catherine Stedman, Christian Schwabe, et al.. (2018). Short‐Duration AL‐335, Odalasvir, With or Without Simeprevir, in Patients With HCV GT1 or 3 Infection Without Cirrhosis. Hepatology. 68(6). 2145–2157. 3 indexed citations

11.

Zhang, Qingling, Justin G. Julander, Antitsa Stoycheva, et al.. (2015). Development of a Hyperglycosylated IFN Alfacon-1 (CIFN): Toward Bimonthly or Monthly Dosing for Antiviral Therapies. Journal of Interferon & Cytokine Research. 35(8). 621–633. 2 indexed citations

12.

Tan, Hua, Kenneth J. Shaw, Jérôme Deval, et al.. (2015). P0682 : Preclinical characterization of AL-335, a potent uridine based nucleoside polymerase inhibitor for the treatment of chronic hepatitis C. Journal of Hepatology. 62. S577–S578. 3 indexed citations

13.

DeVincenzo, John P., Matthew W. McClure, Julian Symons, et al.. (2015). Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study. New England Journal of Medicine. 373(21). 2048–2058. 164 indexed citations

14.

Marcellin, Patrick, Simona Georgiana Popa, Adrian Streinu‐Cercel, et al.. (2013). 866 ALS-2200, A NOVEL ONCE-DAILY NUCLEOTIDE HCV POLYMERASE INHIBITOR, DEMONSTRATED POTENT ANTIVIRAL ACTIVITY IN TREATMENT-NAÏVE PATIENTS WITH COMPENSATED CIRRHOSIS OR GENOTYPE 2–4 CHRONIC HEPATITIS C. Journal of Hepatology. 58. S355–S355. 3 indexed citations

15.

Cooper, Matthew N., Lance O. Lollini, John Allard, et al.. (2009). Testicular gene expression profiling following 2-methoxyethanol and 2-ethoxyethanol exposure in male rats reveals abnormal expression of the actin binding protein cortactin in degenerating spermatocytes. Toxicology Letters. 190(2). 193–201. 4 indexed citations

16.

Morgan, Daniel L., Herman C. Price, Reshan A. Fernando, et al.. (2006). Gestational Mercury Vapor Exposure and Diet Contribute to Mercury Accumulation in Neonatal Rats. Environmental Health Perspectives. 114(5). 735–739. 15 indexed citations

17.

Lassiter, T. Leon, Stephanie Padilla, Spencer R. Mortensen, et al.. (1998). Gestational Exposure to Chlorpyrifos: Apparent Protection of the Fetus?. Toxicology and Applied Pharmacology. 152(1). 56–65. 70 indexed citations

18.

Chanda, Sushmita. (1997). Tissue-Specific Effects of Chlorpyrifos on Carboxylesterase and Cholinesterase Activity in Adult Rats: Anin Vitroandin VivoComparison. Fundamental and Applied Toxicology. 38(2). 148–157. 130 indexed citations

19.

Mortensen, Spencer R., Sushmita Chanda, Michael Hooper, & Stephanie Padilla. (1996). Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos. Journal of Biochemical Toxicology. 11(6). 279–287. 91 indexed citations

20.

Chanda, Sushmita. (1996). Neurochemical and neurobehavioral effects of repeated gestational exposure to chlorpyrifos in maternal and developing rats. Pharmacology Biochemistry and Behavior. 53(4). 771–776. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact